Who is at Risk for Contracting Hepatitis C?
The following individuals are at risk for contracting Hepatitis C:
- People who have injected illicit drugs, even if only one time or a few times, including those who have injected only once many years ago
- Healthcare workers who have been exposed to infectious blood on the job or have been stuck by a needle infected with the Hepatitis C virus
- People who were notified that they received blood from a donor who tested positive after they had already donated their blood
- People who received a blood transfusion or had a solid organ transplant before 1992
- People who have HIV
- People who received blood clotting factor products before 1987
- People who are long-term hemodialysis patients
- People who were born to a woman infected with Hepatitis C
- People who live in a household with an infected person
- People who have/had unprotected sex with multiple partners, and/or between males, particularly where there is a history of a sexually transmitted disease
- People who engage or have engaged in anal sex without a condom
- People who have tattoos and body piercing
- People who have signs or symptoms of liver disease such as abnormal liver enzyme tests
- People who have ever worked or been housed in a prison
Centers for Disease Control and Prevention “Hepatitis C, FAQs for Health Professionals” http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#section1 Retrieved October 28, 2011
HCV Advocate “A Guide to Hepatitis C Treatment Side Effect Management” http://www.hcvadvocate.org/hepatitis/factsheets_pdf/Treatment_Side_effect_Guide.pdf Retrieved October 28, 2011
Hepatitis-Central.com “Hepatitis C Progress Hampered by Re-Infection and Superinfection” http://www.hepatitis-central.com/mt/archives/2009/05/hepatitis_c_pro_1.html Retrieved October 28, 2011
HIVand Hepatitis.com “Telaprevir Plus Standard Therapy Can Produce Hepatitis C Cure in Less Time” http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/3235-telaprevir-plus-standard-therapy-can-produce-hepatitis-c-cure-in-less-time Retrieved October 28, 2011
Journal of General Virology “Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains” http://vir.sgmjournals.org/content/91/5/1183.short Retrieved October 28, 2011
Massage Today “What is Massage?” http://www.massagetoday.com/aboutmt/ Retrieved October 28, 2011
Mayo Clinic “Hepatitis C” http://www.mayoclinic.com/health/hepatitis-c/DS00097 Retrieved October 28, 2011
National Institutes of Diabetes and Digestive and Kidney Diseases “What I Need to Know About Hepatitis C” http://digestive.niddk.nih.gov/ddiseases/pubs/hepc_ez/ Retrieved October 28, 2011
Official Journal of the International Aids Society “Sexually Transmitted Hepatitis C Virus Superinfection in HIV/Hepatitis C Virus co-infected men Who Have Sex With Men” http://journals.lww.com/aidsonline/fulltext/2008/03120/sexually_transmitted_hepatitis_c_virus.16.aspx Retrieved October 28, 2011
U.S. National Library of Medicine National Institutes of Health “Hepatoprotective Properties of Silymarin” http://www.ncbi.nlm.nih.gov/pubmed/21560654 Retrieved October 28, 2011
U.S. National Library of Medicine National Institutes of Health “Milk Thistle in Liver Diseases: Past, Present, Future” http://www.ncbi.nlm.nih.gov/pubmed?term=Milk%20thistle%20in%20liver%20diseases%20past%2C%20present%20and%20future Retrieved October 28, 2011
U.S. National Library of Medicine National Institutes of Health “Multiple effects of silymarin on the hepatitis C virus lifecycle” http://www.ncbi.nlm.nih.gov/pubmed?term=multiple%20effects%20of%20silymarin%20on%20the%20hepatitis%20c%20virus%20lifecycle Retrieved October 28, 2011
U.S. National Library of Medicine National Institutes of Health “Silybin and the Liver: from basic research to clinical practice” http://www.ncbi.nlm.nih.gov/pubmed?term=Silybin%20and%20the%20liver%3A%20from%20basic%20research%20to%20clinical%20practice Retrieved October 28, 2011
Vertex Pharmaceuticals "Medication Guide - Incivek™" http://pi.vrtx.com/files/usmedguide_telaprevir.pdf. Retrieved October 23, 2011.
Merck "Medication Guide - Victrelis™" http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_mg.pdf. Retrieved October 18, 2011.
WebMD “Hepatitis Health Center, Hepatitis C” http://www.webmd.com/hepatitis/hepc-guide/default.htm Retrieved October 28, 2011
World Health Organization “Hepatitis C” http://www.who.int/mediacentre/factsheets/fs164/en/ Retrieved October 28, 2011
Some of our most commonly asked questions and our answers to them.
Tthe latest news on hepatitis treatments, clinical trials, social issues and important breakthroughs.
Learn about the Hepatitis C Virus (HCV).
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Information about the transmission of Hepatitis C.
Learn about Hepatitis C Genotypes and their variants.
Provides detailed information on how to analyze and interpret viral load numbers as well as a link to a convenient Viral Load Chart.
Learn about the importance of testing liver enzyme levels and causes of abnormal levels.
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Learn how hepatitis infection may affect the pregnant mother and baby.
Learn about the conventional medical treatments used to fight Hepatitis C.
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Alternative methods of treatment due to side effects and dissatisfication with current medical treatments.
A number of herbal products useful in the management of liver disease.
Provides information regarding the best known liver supporting supplements.
Provides information regarding the best known milk thistle supplements.
A basic diet for those with Hepatitis C.
Survivor stories that have been shared to benefit others with Hepatitis C.
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
A Bulletin Board for discussions on hepatitis, treatments, etc.